Legis Daily

Pharmaceutical Independence Long-Term Readiness Reform Act

USA116th CongressHR-4710| House 
| Updated: 11/8/2019
John Garamendi

John Garamendi

Democratic Representative

California

Cosponsors (19)
Dusty Johnson (Republican)Elise M. Stefanik (Republican)Jim Hagedorn (Republican)Abigail Davis Spanberger (Democratic)Ed Case (Democratic)Sheila Jackson Lee (Democratic)Debra A. Haaland (Democratic)Steve Cohen (Democratic)Greg Gianforte (Republican)Don Bacon (Republican)Christopher H. Smith (Republican)Pete Stauber (Republican)Ron Wright (Republican)Vicky Hartzler (Republican)Brian K. Fitzpatrick (Republican)Bill Posey (Republican)Scott R. Tipton (Republican)Veronica Escobar (Democratic)Michael Guest (Republican)

Health Subcommittee, Financial Services Committee, Veterans' Affairs Committee, Armed Services Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Pharmaceutical Independence Long-Term Readiness Reform Act This bill generally requires the Department of Defense (DOD) and the Department of Veterans Affairs to only purchase American-made medicines and vaccines. DOD must also (1) report to Congress on medicine supply-chain vulnerabilities, and (2) establish strategies to assure the provision of medicines to enable combat readiness and force health protection.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 17, 2019
Introduced in House
Oct 17, 2019
Referred to the Committee on Armed Services, and in addition to the Committees on Veterans' Affairs, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 17, 2019
Sponsor introductory remarks on measure. (CR E1297-1298)
Nov 8, 2019
Referred to the Subcommittee on Health.
  • October 17, 2019
    Introduced in House
  • October 17, 2019
    Referred to the Committee on Armed Services, and in addition to the Committees on Veterans' Affairs, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • October 17, 2019
    Sponsor introductory remarks on measure. (CR E1297-1298)
  • November 8, 2019
    Referred to the Subcommittee on Health.

Armed Forces and National Security

Buy American requirementsCongressional oversightDrug safety, medical device, and laboratory regulationHealth technology, devices, suppliesImmunology and vaccinationIndustrial policy and productivityManufacturingMilitary medicineMilitary operations and strategyMilitary procurement, research, weapons developmentMilitary readinessPrescription drugsPublic contracts and procurementStrategic materials and reservesVeterans' medical care

Pharmaceutical Independence Long-Term Readiness Reform Act

USA116th CongressHR-4710| House 
| Updated: 11/8/2019
Pharmaceutical Independence Long-Term Readiness Reform Act This bill generally requires the Department of Defense (DOD) and the Department of Veterans Affairs to only purchase American-made medicines and vaccines. DOD must also (1) report to Congress on medicine supply-chain vulnerabilities, and (2) establish strategies to assure the provision of medicines to enable combat readiness and force health protection.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 17, 2019
Introduced in House
Oct 17, 2019
Referred to the Committee on Armed Services, and in addition to the Committees on Veterans' Affairs, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 17, 2019
Sponsor introductory remarks on measure. (CR E1297-1298)
Nov 8, 2019
Referred to the Subcommittee on Health.
  • October 17, 2019
    Introduced in House
  • October 17, 2019
    Referred to the Committee on Armed Services, and in addition to the Committees on Veterans' Affairs, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • October 17, 2019
    Sponsor introductory remarks on measure. (CR E1297-1298)
  • November 8, 2019
    Referred to the Subcommittee on Health.
John Garamendi

John Garamendi

Democratic Representative

California

Cosponsors (19)
Dusty Johnson (Republican)Elise M. Stefanik (Republican)Jim Hagedorn (Republican)Abigail Davis Spanberger (Democratic)Ed Case (Democratic)Sheila Jackson Lee (Democratic)Debra A. Haaland (Democratic)Steve Cohen (Democratic)Greg Gianforte (Republican)Don Bacon (Republican)Christopher H. Smith (Republican)Pete Stauber (Republican)Ron Wright (Republican)Vicky Hartzler (Republican)Brian K. Fitzpatrick (Republican)Bill Posey (Republican)Scott R. Tipton (Republican)Veronica Escobar (Democratic)Michael Guest (Republican)

Health Subcommittee, Financial Services Committee, Veterans' Affairs Committee, Armed Services Committee

Armed Forces and National Security

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Buy American requirementsCongressional oversightDrug safety, medical device, and laboratory regulationHealth technology, devices, suppliesImmunology and vaccinationIndustrial policy and productivityManufacturingMilitary medicineMilitary operations and strategyMilitary procurement, research, weapons developmentMilitary readinessPrescription drugsPublic contracts and procurementStrategic materials and reservesVeterans' medical care